Should I take Nivolumab for stage 2B nodular melanoma at age 75?

Posted by matt75 @matt75, Jul 17 12:33am

My pet scan was clear and had an excision and lymph node removal and was clear there. My oncologist wants to have me to take a 17-course treatment of immunotherapy drug Nivolumab. I worry about the side effects and wonder if at 75 years old just monitoring it with scans and skin examinations would be enough. Meeting with my doctor next week to discuss. Does anyone have any thoughts or experience with this drug?

Interested in more discussions like this? Go to the Melanoma & Skin Cancer Support Group.

That’s impressive with your father and father-in-law. That’s a good question you bring up about a future recurrence and I will ask him. Maybe how quickly the recurrence comes is a factor also. As far as tools, I try to read as much as I can about melanoma including studies, some books, and follow a few Facebook forums(with care). The American Institute of Melanoma has quite a bit of information. MDAnderson where I go has a Zoom men’s cancer support group that helps with the overall treatment world. Like you say, we didn’t have anything to say about getting into this and we’re all trying hard to get through it. Thanks.

REPLY
Profile picture for joetex @joetex

That’s impressive with your father and father-in-law. That’s a good question you bring up about a future recurrence and I will ask him. Maybe how quickly the recurrence comes is a factor also. As far as tools, I try to read as much as I can about melanoma including studies, some books, and follow a few Facebook forums(with care). The American Institute of Melanoma has quite a bit of information. MDAnderson where I go has a Zoom men’s cancer support group that helps with the overall treatment world. Like you say, we didn’t have anything to say about getting into this and we’re all trying hard to get through it. Thanks.

Jump to this post

@joetex The institute that I referred to is called AIM at Melanoma . My mistake.

REPLY
Please sign in or register to post a reply.